BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/64/0.1/20.09.24 | Market Closed - Deutsche Boerse AG 11:20:22 07/06/2024 pm IST | ||
| 0.024 EUR | +20.00% |
|
| Current month | -20.00% | ||
| 1 month | -51.02% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 07/24/07 | 0.024 | +20.00% |
| 06/24/06 | 0.02 | -35.48% |
| 05/24/05 | 0.031 | +40.91% |
| 04/24/04 | 0.022 | -42.11% |
| 03/24/03 | 0.038 | +26.67% |
Delayed Quote Deutsche Boerse AG
Last update June 07, 2024 at 11:20 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM7PAH |
| ISIN | DE000VM7PAH6 |
| Date issued | 29/12/2023 |
| Strike | 64 $ |
| Maturity | 20/09/2024 (105 Days) |
| Parity | 10 : 1 |
| Emission price | 0.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.36 € |
|---|---|
| Lowest since issue | 0.009 € |
| Spread | 0.01 € |
| Spread % | 26.32% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
88.14
USD
Average target price
96.31
USD
Spread / Average Target
+9.27%
- Stock Market
- Warrants
- Warrant
